Implantable Cardioverter Defibrillator Market Size to Reach USD 8.81 Billion in 2028 | Surge in Contributing Factors Such as Obesity and Sedentary Lifestyle is a Key Factor Driving Industry Growth, says Emergen Research

VANCOUVER, BC, July 26, 2021 /PRNewswire/ -- The global Implantable Cardioverter Defibrillator (ICD) market size is expected to reach USD 8.81 Billion at a steady CAGR of 2.7% in 2028, according to latest analysis by Emergen Research. Global implantable cardioverter defibrillator market revenue growth is driven by rising focus on public-access defibrillators and training and awareness programs on ICDs. Changing lifestyle and habits, increasing alcohol consumption and tobacco smoking are some other major factors expected to contribute significantly to market revenue growth.

ICDs are used to prevent sudden death in patients due to fibrillation or continuous ventricular tachycardia. ICDs can prevent cardiac arrest in patients who are at high-risk of life-threatening arrhythmias. Next generation ICDs can also play a role of pacemaker. The pacemaker feature can stimulate the heart to beat if the heart rate slows down.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/732

Heart disease is one of the major causes of death globally. Cardiovascular disease is the cause of over 17.9 million deaths, and more than 655,000 Americans die from heart disease each year. Surge in number of deaths due to heart diseases each year is resulting in rising focus on reducing these numbers, which is driving demand for ICDs in countries across the globe. Rising incidence of obesity is resulting in various heart complications, which is supporting demand for ICDs. However, risks such as infection in the implanted areas, and damage to veins where ICDs are placed are factors that restrain deployment and preference among some patients, which can hamper market revenue growth to some extent. Increased investments in R&D for improved and more effective ICDs is also expected to contribute to revenue growth of the market.

Some Key Highlights From the Report

• Major players in the market include Boston Scientific Corporation, Abbott Laboratories, Biotronik, Medtronic PLC, LivaNova PLC, MicroPort, Sorin Group, Koninklijke Philips N.V., Fukuda Denshi Co. Ltd., and Physio-Control, Inc.
• In June 2020, Biotronik and Acutus Medical announced entering into partnership to collaborate on specific electrophysiology-related products. Biotronik is engaged in development of devices for cardiac rhythm management with primary focus on implantable devices. Under the partnership, Acutus will market Biotronik's electrophysiology ablation products under a private label. The partnership will enable provision of powerful clinical solutions for people suffering from atrial fibrillation and heart rhythm disorders.
• Transvenous implantable cardioverter defibrillator segment accounted for a significantly large revenue share in 2020. Transvenous ICD were developed to simplify the implant procedure and to reduce morbidity of thoracotomy for implantation. These ICDs have improved mortality rate in multiple randomized, controlled trials over the past two decades. Transvenous ICDs segment is further segmented into single chamber ICD, dual chamber ICD, and CRT-D. 
• Hospitals & clinics segment accounted for largest revenue share in 2020 as these facilities are equipped with more advanced and automated ICD devices. Government initiatives to improve healthcare facilities and integrate modern technologies to help save lives of patients suffering from various heart diseases is also driving revenue growth of this segment. Emergence of new hospitals in developing countries will also contribute significantly to market revenue growth going ahead.
• North America accounted for largest revenue share in 2020 due to high demand from the U.S. Rapid adoption of advanced technologies in the U.S. and integration of Artificial Intelligence (AI) and Machine Learning (ML) in the healthcare sector is contributing to high demand for ICDs in countries in the region. Rapidly increasing geriatric population and increase in prevalence of cardiac diseases are key factors fueling North America market revenue growth.

Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/732

Emergen Research has segmented the global implantable cardioverter defibrillator market on the basis of product type, end-use, and region:

• Product Type Outlook (Revenue, USD Billion; 2018–2028)
• Transvenous ICD
• a. Single Chamber ICD
• b. Dual Chamber ICD
• c. CRT-D (cardiac resynchronization therapy-defibrillator)
• Subcutaneous ICD
• End-use Channel Outlook (Revenue, USD Billion; 2018–2028)
• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/implantable-cardioverter-defibrillator-market

• Regional Outlook (Revenue, USD Billion; 2018–2028)
• North America
• a. U.S.
• b. Canada
• c. Mexico
• Europe
• a.  Germany
• b. U.K.
• c.  France
• d.  Spain
• e.  BENELUX
• f.  Italy
• g.  Rest of Europe
• Asia Pacific
• a.  China
• b.  India
• c.  Japan
• d.  South Korea
• e.  Rest of APAC
• Latin America
• a.  Brazil
• b.  Rest of LATAM
• Middle East & Africa
• a.  Saudi Arabia
• b.  UAE
• c.  Israel
• d.  Rest Of MEA

Explore more reports offered by Emergen Research:

Single Use/Disposable Endoscopy Market By Product (Endoscope, Visualization Systems, Endoscopic Ultrasound, Insufflator), By Application (Bronchoscopy, Urologic Endoscopy, Arthroscopy, GI endoscopy, ENT Endoscopy, Others), By End-use (Hospitals, Healthcare Centers, Clinics), and By Region Forecast to 2028

Oncolytic Virus Therapies Market Size, Share, Trends, By Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), By Application (Solid Tumors, Melanoma), By End-use (Hospitals, Specialty Clinics, Cancer Research Institute), and By Region, Forecast to 2028.

Hybrid Operating Room Market Size, Share, Trends, By Component (Surgical Instruments, Audiovisual Display Systems and Tools, Intraoperative Diagnostic Imaging Systems, Operating Room Fixtures), By Application, By End-use, and By Region and Country Forecast to 2028

Nanorobotics Market Size, Share, Trends, By Type (Nanomanipulator, Bio-Nanorobotics, Magnetically Guided, Bacteria-Based), By Application (Nanomedicine, Biomedical, Mechanical, Others), and By Region Forecast to 2028

Nanotechnology Companies to Watch Out for in the Near Future

Top 10 Leading Facemask Manufacturing Companies in the World

Microfluidics: Miniaturizing Conventionally Sized Systems to Develop High-Precision Approaches

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. For more information, visit

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com 
Facebook | LinkedIn | Twitter | Blogs 
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-implantable-cardioverter-defibrillator-market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg